Medication info

Enstillum Foam

Prescription medicationApproval withdrawn
Ingredient · strength
Calcipotriol›52.2μg / 1gBetamethasone Dipropionate›0.643mg / 1g
Manufacturer / importer
LEO Pharma
Appearance
It is a white or pale yellowish foam.
Packaging
60g/can
Approval status
Approval withdrawn

MFDS item code 201607369 · Approved 2016.12.29 · Insurance code 626700101

This product's status changed to Approval withdrawn on 2025.09.16. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Topical treatment of plaque psoriasis in adults and adolescents aged 12 years and older
Who uses it
Adults
Adult dosage
Apply this drug to the affected area once daily. The recommended treatment period is 4 weeks. If treatment is to be continued or restarted after this period, it should be done under a physician's supervision. Maintenance therapy (adults 18 years of age and older only) Patients who have responded to treatment with this drug once daily for 4 weeks are suitable for maintenance therapy. For maintenance treatment, apply this drug to all areas previously affected by psoriasis vulgaris twice weekly on 2 nonconsecutive days. Applications should be spaced 3 or 4 days apart. At signs of recurrence, resume once-daily application according to the method for topical treatment. The maximum dose must not exceed 15g per day. Each can contains 60g, which is enough for at least 4 days of use. 15g is the amount dispensed when the actuator is pressed fully for approximately 1 minute. Spraying for 2 seconds dispenses approximately 0.5g of medication. 0.5g of foam covers an area approximately equivalent to the surface of an adult's palm. The body surface area to which the calcipotriol contained in this product is applied must not exceed 30%. If used concomitantly with another medicinal product containing calcipotriol, the total amount of all medicinal products containing calcipotriol, including this drug, must not exceed 15g per day. Method of administration: Shake the can for a few seconds before use. When applying this drug, spray from a distance of at least 3cm from the skin. The foam may be sprayed in any direction except when the can is positioned horizontally. After spraying this drug onto the affected area, rub it in gently. Wash hands immediately after using this drug to prevent it from contacting other areas of the body. Showering or bathing immediately after applying this drug is not recommended. Do not use more than 60g every 4 days. This drug must not be used with occlusive dressings unless under the supervision of a physician. Avoid use on the face, groin, and armpits, and on areas where skin atrophy has developed in the treatment area.

Ingredients

Importer
LEO Pharma

Efficacy & effects

Topical treatment of plaque psoriasis in adults and adolescents aged 12 years and older

  • Plaque psoriasis
View approved original text

This medication is primarily used for the local treatment of plaque psoriasis in adolescents and adults aged 12 years and older. Plaque psoriasis is characterized by red and scaly patches on the skin, causing significant discomfort. This medication helps improve the skin condition and relieve symptoms. With consistent use, it reduces itching and inflammation and promotes the recovery of healthy skin.

Dosage and Administration

Adult dosage

Apply this drug to the affected area once daily. The recommended treatment period is 4 weeks. If treatment is to be continued or restarted after this period, it should be done under a physician's supervision. Maintenance therapy (adults 18 years of age and older only) Patients who have responded to treatment with this drug once daily for 4 weeks are suitable for maintenance therapy. For maintenance treatment, apply this drug to all areas previously affected by psoriasis vulgaris twice weekly on 2 nonconsecutive days. Applications should be spaced 3 or 4 days apart. At signs of recurrence, resume once-daily application according to the method for topical treatment. The maximum dose must not exceed 15g per day. Each can contains 60g, which is enough for at least 4 days of use. 15g is the amount dispensed when the actuator is pressed fully for approximately 1 minute. Spraying for 2 seconds dispenses approximately 0.5g of medication. 0.5g of foam covers an area approximately equivalent to the surface of an adult's palm. The body surface area to which the calcipotriol contained in this product is applied must not exceed 30%. If used concomitantly with another medicinal product containing calcipotriol, the total amount of all medicinal products containing calcipotriol, including this drug, must not exceed 15g per day. Method of administration: Shake the can for a few seconds before use. When applying this drug, spray from a distance of at least 3cm from the skin. The foam may be sprayed in any direction except when the can is positioned horizontally. After spraying this drug onto the affected area, rub it in gently. Wash hands immediately after using this drug to prevent it from contacting other areas of the body. Showering or bathing immediately after applying this drug is not recommended. Do not use more than 60g every 4 days. This drug must not be used with occlusive dressings unless under the supervision of a physician. Avoid use on the face, groin, and armpits, and on areas where skin atrophy has developed in the treatment area.

Precautions

This medication is flammable; therefore, it is essential to avoid fire hazards such as flames, cigarettes, and fire sources while using it. This medication contains corticosteroid components, which may cause side effects such as adrenal suppression, worsening diabetes, and osteoporosis if absorbed systemically. Particularly, when using occlusive dressings or applying to large skin areas, damaged skin, or areas where the skin folds, there is a higher risk of systemic absorption, and caution should be exercised. If this medication is used for an extended period or over large areas, it is necessary to regularly check hormone levels such as blood cortisol concentration. Due to the calcipotriene component, hypercalcemia may occur, so use should be discontinued immediately if this symptom appears. This medication should not be used in individuals who are hypersensitive to it, have calcium metabolism disorders, certain types of psoriasis, infected skin, children under 12 years of age, or on facial or mucosal areas. Elderly individuals, patients with liver disease, and diabetics must exercise additional caution when using this medication, as it may impact blood sugar control. If localized side effects such as skin redness, itching, or irritation occur during use, discontinue immediately and consult a doctor. If it gets into the eyes, rinse immediately with clean water, and if symptoms are severe, seek ophthalmic care. It is preferable not to use this medication concurrently with other topical corticosteroids, and efficacy may be diminished when combined with salicylic acid. Pregnant or breastfeeding women should consult a doctor before using this medication, especially during the early stages of pregnancy, where caution is advised. Children under 12 years are not recommended for use, as safety and efficacy have not been established. Excessive use may lead to elevated blood calcium levels or adrenal function suppression, so it is crucial to strictly adhere to the prescribed dosage and regimen. After use, store in a place out of reach of children, and it is safer to use within six months after opening. It is recommended to avoid or limit sun exposure after using this medication, and if skin irritation or abnormal reactions occur, discontinue use and consult a professional.

Side effects

  • Folliculitis
  • hypersensitivity
  • hypercalcemia
  • decreased skin pigmentation
  • hair color change
  • rebound effect
  • injection site pain
  • injection site itching
  • injection site irritation
  • injection site erythema
Show 26 more
  • injection site reaction
  • itching
  • skin irritation
  • burning sensation and pain
  • dry skin
  • erythema
  • rash
  • dermatitis
  • eczema
  • worsening of psoriasis
  • photosensitivity
  • angioedema
  • facial swelling
  • skin atrophy
  • telangiectasia
  • purpura
  • hypertrichosis
  • perioral dermatitis
  • allergic contact dermatitis
  • pigment loss
  • milia
  • cataract
  • infection
  • impaired blood sugar control in diabetes
  • increased intraocular pressure
  • blurred vision

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to keep it at room temperature, specifically between 1 and 30 degrees Celsius. This way, the medication's effectiveness can be maintained for an extended period.

Appearance and packaging

Appearance

It is a white or pale yellowish foam.

Package unit

60g/can

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.